reviewTop 1% cited

The relevance of primary tumour location in patients with metastatic colorectal cancer: A meta-analysis of first-line clinical trials

European Journal of Cancer · 2016 · Vol. 70 · pp. 87–98

Julian Walter Holch✉(Ludwig-Maximilians-Universität München)Ingrid Ricard✉(Zimmer Biomet (Netherlands))Sebastian Stintzing✉(Ludwig-Maximilians-Universität München)Dominik Paul Modest✉(Ludwig-Maximilians-Universität München)Volker Heinemann✉(Ludwig-Maximilians-Universität München)

View via DOI Publisher page

Colorectal Cancer Treatments and Studies Genetic factors in colorectal cancer Gastric Cancer Management and OutcomesMedicineInternal medicineHazard ratioOncologyBevacizumabColorectal cancerMeta-analysisChemotherapySubgroup analysisConfidence interval

MeSH terms

Antibodies, MonoclonalAntineoplastic Combined Chemotherapy ProtocolsHumansPrognosisRetrospective StudiesColorectal NeoplasmsSurvival AnalysisRandomized Controlled Trials as TopicAngiogenesis InhibitorsVascular Endothelial Growth Factor AErbB Receptors

Citations

528

FWCI

30.57

field-weighted impact

References

Percentile

100%

vs. same field & year

Citations per year

Cited by

Prognostic and predictive value of primary tumour side in patients with RAS wild-type metastatic colorectal cancer treated with chemotherapy and EGFR directed antibodies in six randomized trials